About: Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.43 (+1.42%)
XCURNASDAQExicure Inc
Loading watchlist status…
Exicure Inc share price
XCUR price activity
Last Price
$1.430
Change (24hr)
0.02 USD (1.42%)
Volume
221.38K
Volume (4w avg)
-
Open
$1.45
Day Range
$1.40 - $1.60
Previous Close
$1.41
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
XCUR price performance
10%
5D
6.32%
1M
-73.62%
YTD
-65.54%
1Y
Delayed
09 Sep, 8:00 pm GMT+0
XCUR Market Signals